Infinity Pharmaceuticals Announces Its Participation at Three Investor Conferences
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it
will be participating in the 14th Annual BIO CEO & Investor
Conference on Monday, February 13, 2012, at 3:00 p.m. ET and in the 2012
Citi Global Healthcare Conference on Monday, February 27, 2012, at 11:00
a.m. ET. Both conferences will take place in New York City. A live
webcast of these two conferences will be accessible on the
“investors/media” section of the company's website, www.infi.com,
and will be available for 30 days following the event.
In addition, Infinity will also be attending the UBS Small/Mid-Cap
Conference in Boston, February 28-29, 2012. While there is no formal
presentation during the UBS Symposium, management will be available for
one-on-one meetings during the conference.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative drug discovery and development company seeking
to discover, develop, and deliver to patients best-in-class medicines
for difficult-to-treat diseases. Infinity combines proven scientific
expertise with a passion for developing novel small molecule drugs that
target emerging disease pathways. Infinity’s programs in the inhibition
of the Hedgehog pathway, the Hsp90 chaperone system and
phosphoinositide-3-kinase are evidence of its innovative approach to
drug discovery and development. For more information on Infinity, please
refer to the company’s website at www.infi.com.